Venus Remedies surges on partnering with West Pharmaceutical Services to launch Cloti-Xa in India

Venus Remedies is currently trading at Rs. 289.65, up by 13.75 points or 4.98% from its previous closing of Rs. 275.90 on the BSE.

The scrip opened at Rs. 284.00 and has touched a high and low of Rs. 289.65 and Rs. 270.00 respectively. So far 12546 shares were traded on the counter.

The BSE group 'B' stock of face value Rs. 10 has touched a 52 week high of Rs. 314.10 on 24-Mar-2021 and a 52 week low of Rs. 28.35 on 13-Apr-2020.

Last one week high and low of the scrip stood at Rs. 302.85 and Rs. 270.00 respectively. The current market cap of the company is Rs. 336.69 crore.

The promoters holding in the company stood at 35.89%, while Institutions and Non-Institutions held 0.04% and 64.07% respectively.

Venus Remedies has inked partnership with West Pharmaceutical Services, Inc., a global leader in innovative solutions for injectable drug administration, for its new introduction in the fast-growing low molecular weight heparin market with brand Cloti-Xa, which has adopted NovaGuard SA Pro safety system, a single-use accessory for prefilled ISO standard 1mL long staked-needle syringes.

Cloti-Xa which contains enoxaparin sodium is being introduced with added advantage of NovaGuard SA Pro safety system which is a revolutionary product that helps and protects healthcare workers and patients from accidental needle stick injuries. This innovative product has been commented to deliver a compelling total cost of ownership in that it prevents pre-activation, offers a lower syringe snap-in force and a lower activation force for end-user comfort, and mitigates the practice of recapping which helps to provide tamper evidence to customers.

Venus Remedies is one of the handful player in pharmaceutical sector to launch world global injectable manufacturers. It has world-class manufacturing facilities in Panchkula and Baddi (in India) and Werne (in Germany) and research and development center in Venus Medicine Research Centre (in India).